Barclays analyst Charles Pitman CFA reiterated a Buy rating on UCB SA (0NZT – Research Report) today and set a price target of €240.00. The company’s shares closed last Friday at €188.86.

Copyright © 2025 MarketWatch, Inc. All rights reserved.

Belgian biopharma UCB has been given the green light by the FDA for Zilbrysq as a treatment for generalised myasthenia gravis (gMG), one of two drugs that the company hopes will shake up the ...

The double ‘R’ in the Ray-Ban logo mirrors the shape of their most popular product, aviator sunglasses. This symmetry is an important design element that gives the brand a recognisable mark. These ...

Now, researchers have found the first evidence of changes taking place over the past 20 years in the shape of the inner core. Signs of the core’s deformation appeared in waves from earthquakes ...

Roche already has one Alzheimer’s candidate in its pipeline targeting tau, but has added a second via a deal with Belgian drugmaker UCB worth up to $2 billion. The Swiss pharma group is paying $ ...

Two-dimensional (2D) shapes are completely flat. They have two dimensions – length and width. A polygon is a closed 2D shape with straight sides that meet at vertices. Polygons can be regular or ...

With that result, all 32 first-round picks are locked in for the three-day event in April. The Tennessee Titans have the No. 1 pick, followed by the Cleveland Browns, New York Giants, New England ...

If you’re looking to treat yourself or a loved one to something special for the holiday, the team at Google Trends has gathered data on the most uniquely-searched heart-shaped products across ...

Hear, Thatcher Demko Speak with the media following his shutout in tonight's home game.

The JackJumpers are searching for the next artist to design their Indigenous round jersey for the 2025/26 NBL season. Last year’s jersey, which symbolised a connection to the land and sea, was created ...